Dementia May Occur Less Often, Develop Slower in Parkinson Disease Patients
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Aug. 7, 2024 -- For patients with Parkinson disease (PD), dementia may occur less often or develop over a longer time period than previously thought, according to a study published online Aug. 7 in Neurology.
Julia Gallagher, from the University of Pennsylvania in Philadelphia, and colleagues determined long-term dementia risk among participants from the Parkinson's Progression Markers Initiative (PPMI) multisite international study and a long-standing PD research cohort at the University of Pennsylvania (Penn). A total of 417 participants with PD were followed for the PPMI cohort, and 389 participants with PD were followed for the Penn cohort.
The researchers found that the estimated probability of dementia at year 10 disease duration was 9, 15, and 12 percent for site investigator diagnosis, according to the Montreal Cognitive Assessment, and according to the Movement Disorder Society-Unified Parkinson's Disease Rating Scale, respectively, in the PPMI cohort; 47 percent of the Penn cohort was eventually diagnosed with dementia. The median time to dementia was 15 years in the interval-censored curve for the Penn cohort, with estimated probabilities of dementia of 27, 50, and 74 percent at 10, 15, and 20 years of disease duration, respectively.
"These results provide updated, and more hopeful, estimates of long-term dementia risk in PD, suggesting a longer window to intervene to prevent or delay cognitive decline," the authors write.
Several authors disclosed ties to the biopharmaceutical industry; the PPMI is partially funded by biopharmaceutical companies.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-08-08 07:15
Read more
- Heat Waves Linked to Adverse Health Outcomes for Seniors
- Transitioning to E-Cigarettes Aids Resolution of Respiratory Symptoms
- Skin Patch Could Monitor Your Blood Pressure
- Arrowhead Pharmaceuticals Submits New Drug Application to U.S. FDA for Plozasiran for the Treatment of Familial Chylomicronemia Syndrome
- Orexo initiates new study of OX640 in participants with allergic rhiniti
- ACR: Inebilizumab Reduces Risk for Flares in IgG4-Related Disease
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions